Ticker Details
Theravance Biopharma, Inc. Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics.
IPO Date:	May 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$852.21M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.39 | 2.11%
Avg Daily Range (30 D):	$0.27 | 1.75%
Avg Daily Range (90 D):	$0.30 | 1.70%

Institutional Daily Volume
Avg Daily Volume:	.34M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	.43M

Trade Size
Avg Trade Size (Sh.):	89
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	2,223
Avg Institutional Trade:	$1.4M
Avg Institutional Trade (30 D):	$1.99M
Avg Institutional Trade (90 D):	$1.62M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.2M
Avg Closing Trade (30 D):	$2.37M
Avg Closing Trade (90 D):	$1.68M
Avg Closing Volume:	75.71K

News

Apr 3, 2026 @ 12:48 AM TBPH Investors Have Opportunity to Join Theravance... Source: Schall Law Firm

Mar 3, 2026 @ 6:19 PM Theravance Biopharma Plummets As Phase 3 Study Fal... Source: Vandana Singh

Feb 22, 2026 @ 3:08 PM Irenic Dumps Most Papa John's Shares Source: Lawrence Rothman, Cfa

Jan 19, 2026 @ 12:37 PM Neurogenic Orthostatic Hypotension (nOH) Global Cl... Source: Researchandmarkets.Com

Aug 13, 2025 @ 2:13 AM Theravance Sales Jump 83 Percent Source: Jesterai

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.1	$1.2	$2.1
Diluted EPS	$2.06	$1.15	$2.06
Revenue	$107.46M	$45.89M	$107.46M
Gross Profit
Net Income / Loss	$105.9M	$61.02M	$105.9M
Operating Income / Loss	$-3.6M	$20.01M	$-3.6M
Cost of Revenue
Net Cash Flow	$130.01M	$-6.97M	$130.01M
PE Ratio	7.94